PanoramicaGraficoNotizieSchermataTrader

BIOVERATIV ORD SHS/  US09075E1001  /

London International
-  - Var. - Volume Denaro- Lettera- Max Min
-USD - -
Fatturato: -		 -Quantità in denaro: - -Quantità in lettera: - - -
GlobeNewswire 02/04 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 25/03 Dyne Therapeutics Announces CEO Transition
GlobeNewswire 22/02/2022 Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., as Chief Technical Operations Officer
GlobeNewswire 04/02/2022 Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
GlobeNewswire 05/01/2022 Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of R...
GlobeNewswire 28/10/2021 Sanofi : Strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER(1)
GlobeNewswire 08/09/2021 Attralus Closes $116 Million Series B Financing
GlobeNewswire 08/09/2021 Fulcrum Therapeutics™ Appoints Mel Hayes as Chief Commercial Officer
GlobeNewswire 29/07/2021 Sales growth accelerated - Full-year guidance raised
GlobeNewswire 28/04/2021 Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER
GlobeNewswire 07/04/2021 Arch Oncology Appoints Laurence Blumberg, M.D. President and CEO
GlobeNewswire 16/03/2021 GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Progr...
GlobeNewswire 05/02/2021 Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER
GlobeNewswire 29/10/2020 Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER
GlobeNewswire 17/09/2020 OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
GlobeNewswire 29/07/2020 Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation
GlobeNewswire 06/05/2020 Oxford Biomedica plc Preliminary results for the year ended 31 December 2019
GlobeNewswire 24/04/2020 Sanofi at forefront of fight against COVID-19 in Q1 2020
GlobeNewswire 06/02/2020 Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
GlobeNewswire 31/10/2019 Sanofi Q3 well on track
GlobeNewswire 04/09/2019 Oxford Biomedica Interim Results
GlobeNewswire 27/08/2019 Amunix Pharmaceuticals Announces the Appointment of Dr. Maninder Hora as Chief Technical Operations ...
GlobeNewswire 02/08/2019 The Global Gene Therapy Market, 2019 to 2024: Product Pipeline, Market Size, and Forecasts
GlobeNewswire 31/07/2019 Apellis Pharmaceuticals Reports Second Quarter 2019 Business Update and Financial Results
GlobeNewswire 29/07/2019 Sanofi delivered solid growth in Q2 2019